Alexander Haug
Alexander Haug
Associate Professor and Deputy Director of the Division of Nuclear Medicine, Medical University of
Email verificata su
Citata da
Citata da
Survival after yttrium‐90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation
B Sangro, L Carpanese, R Cianni, R Golfieri, D Gasparini, S Ezziddin, ...
Hepatology 54 (3), 868-878, 2011
Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours
A Haug, CJ Auernhammer, B Wängler, R Tiling, G Schmidt, B Göke, ...
European journal of nuclear medicine and molecular imaging 36 (5), 765-770, 2009
Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival
RT Hoffmann, PM Paprottka, A Schön, F Bamberg, A Haug, EM Dürr, ...
Cardiovascular and interventional radiology 35 (1), 105-116, 2012
68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor–mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors
AR Haug, CJ Auernhammer, B Wängler, GP Schmidt, C Uebleis, B Göke, ...
Journal of nuclear medicine 51 (9), 1349-1356, 2010
In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET/CT: correlation with coronary calcium burden and risk factors
A Rominger, T Saam, E Vogl, C Übleis, C la Fougère, S Förster, A Haug, ...
Journal of nuclear medicine 51 (2), 193-197, 2010
Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG–PET–CT
GP Schmidt, A Baur-Melnyk, A Haug, V Heinemann, I Bauerfeind, ...
European journal of radiology 65 (1), 47-58, 2008
The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors
AR Haug, R Cindea-Drimus, CJ Auernhammer, M Reincke, B Wängler, ...
Journal of nuclear medicine 53 (11), 1686-1692, 2012
Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin’s disease and non-Hodgkin’s lymphoma
C la Fougère, W Hundt, N Bröckel, T Pfluger, A Haug, B Scher, M Hacker, ...
European journal of nuclear medicine and molecular imaging 33 (12), 1417-1425, 2006
Detection of low-grade prosthetic joint infections using 99mTc-antigranulocyte SPECT/CT: initial clinical results
V Graute, M Feist, S Lehner, A Haug, PE Müller, P Bartenstein, M Hacker
European journal of nuclear medicine and molecular imaging 37 (9), 1751-1759, 2010
Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer
GP Schmidt, A Baur-Melnyk, A Haug, S Utzschneider, CR Becker, R Tiling, ...
European radiology 19 (6), 1366-1378, 2009
Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres
PM Paprottka, RT Hoffmann, A Haug, WH Sommer, F Raeßler, CG Trumm, ...
Cardiovascular and interventional radiology 35 (2), 334-342, 2012
18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer
AR Haug, BPT Donfack, C Trumm, CJ Zech, M Michl, RP Laubender, ...
Journal of Nuclear Medicine 53 (3), 371-377, 2012
Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma
FT Kolligs, JI Bilbao, T Jakobs, M Iñarrairaegui, JM Nagel, M Rodriguez, ...
Liver international 35 (6), 1715-1721, 2015
Whole-body MRI and PET-CT in the management of cancer patients
GP Schmidt, AR Haug, SO Schoenberg, MF Reiser
European radiology 16 (6), 1216-1225, 2006
Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer
WP Fendler, DBP Tiega, H Ilhan, PM Paprottka, V Heinemann, TF Jakobs, ...
Journal of Nuclear Medicine 54 (8), 1202-1208, 2013
Current status of theranostics in prostate cancer
I Virgolini, C Decristoforo, A Haug, S Fanti, C Uprimny
European journal of nuclear medicine and molecular imaging 45 (3), 471-495, 2018
Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma
R Golfieri, JI Bilbao, L Carpanese, R Cianni, D Gasparini, S Ezziddin, ...
Journal of hepatology 59 (4), 753-761, 2013
18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres
AR Haug, V Heinemann, CJ Bruns, R Hoffmann, T Jakobs, P Bartenstein, ...
European journal of nuclear medicine and molecular imaging 38 (6), 1037-1045, 2011
Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue
W Rachinger, VM Stoecklein, NA Terpolilli, AR Haug, L Ertl, J Pöschl, ...
Journal of Nuclear Medicine 56 (3), 347-353, 2015
Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients
A Klingenstein, AR Haug, CJ Zech, UC Schaller
Cardiovascular and interventional radiology 36 (1), 158-165, 2013
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20